[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2018[J].CA Cancer J Clin,2018,68(1):7-30.
[2] MA J Q,Yang Y,Juan J,et al.Over-expression of prolyl isomerase pin1 promotes cervical tumorigenesis and metastasis[J].Int J Clin Exp Pathol,2018,11(2):664-674.
[3] GE Y,ZHANG C,XIAO S,et al.Identification of differentially expressed genes in cervical cancer by bioinformatics analysis[J].Oncol Lett,2018,6(2):2549-2558.
[4] 丁岳,周怀君.宫颈癌预后生物学指标新进展[J].东南大学学报(医学版),2019,38(1):192-195.
[5] GUTHRIE G J,ROXBURGH C S,FARHAN-ALANIE O M,et al.Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer[J].Br JCancer,2013,109(1):24-28.
[6] WU J,GE XX,ZHU W,et al.Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer[J].Mol Med Rep,2019,19(3):2330-2340.
[7] WANG YL,GE XX,WANG Y,et al.The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers[J].BMC Gastroenterol,2018,18(1):99.
[8] 吴艳,李炜虹,居锦芬.宫颈病变的早期筛查及绝经妇女异常筛查结果的临床分析[J].现代医学,2018,46(9):1002-1006.
[9] 魏丽惠.子宫颈癌筛查——从细胞学检查到HPV检测[J].中华妇产科杂志,2019,54(5):289-292.
[10] GRIVENNIKOV S I,GRETEN F R,KARIN M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
[11] KITAMURA T,QIAN B Z,POLLARD J W.Immune cell promotion of metastasis[J].Nat Rev Immunol,2015,15(2):73-86.
[12] WANG S C,CHOU J F,STRONG V E,et al.Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma[J].Ann Surg,2016,263(2):292-297.
[13] CHEN L,ZHANG F,SHENG XG,et al.Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery[J].Onco Targets Ther,2015,8:1355-1362.
[14] LEE S,EO W,JEON H,et al.Prognostic significance of host-related biomarkers for survival in patients with advanced non-small cell lung cancer[J].JCancer,2017,8(15):2974-2983.
[15] ERIKSEN A C,SORENSEN F B,LINDEBJERG J,et al.The prognostic value of tumor-infiltrating lymphocytes in stage II colon cancer.A nationwide population-based study[J].Transl Oncol,2018,11(4):979-987.
[16] TOSS M S,MILIGY I,Al-KAWAZ A,et al.Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast[J].Mod Pathol,2018,31(8):1226-1236.
[17] ZHOU C,WU Y,JIANG L,et al.Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma[J].J Oral Pathol Med,2018,47(4):359-367.
[18] ZIKOS T A,DONNENBERG A D,LANDRENEAU R J,et al.Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer[J].Cancer Immunol Immunother,2011,60(6):819-827.
[19] HIRAOKA K,MIYAMOTO M,CHO Y,et al.Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma[J].Br J Cancer,2006,94(2):275-280.
[20] LEE Y Y,CHOI C H,SUNG C O,et al.Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer[J].Gynecol Oncol,2012,127(1):107-113.
[21] HARBAUM L,POLLHEIMER M J,KORNPRAT P,et al.Peritumoral eosinophils predict recurrence in colorectal cancer[J].Mod Pathol,2015,28(3):403-413.
[22] HELBIG G,SOJA A,BARTKOWSKA-CHROBOK A,et al.Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation[J].Am J Hematol,2012,87(6):643-645.
[23] DAVIS B P,ROTHENBERG M E.Eosinophils and cancer[J].Cancer Immunol Res,2014,2(1):1-8.
[24] WANG D,DBBOIS R N.Eicosanoids and cancer[J].Nat RevCancer,2011,10(3):181-193. |